Merck & Co Inc
XMUN:6MK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
Deutsche Telekom AG
MIL:DTE
|
DE |
|
G
|
Getlink SE
XMUN:TNU3
|
FR |
|
B
|
Boeing Co
XHAM:BCO
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
|
T
|
Thai Union Feedmill PCL
SET:TFM
|
TH |
|
P
|
Pfizer Inc
DUS:PFE
|
US |
|
V
|
Vinci SA
XBER:SQU
|
FR |
|
V
|
Verizon Communications Inc
DUS:BAC
|
US |
|
C
|
CNOOC Ltd
F:NC2B
|
CN |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
|
K
|
KeyCorp
XMUN:KEY
|
US |
|
N
|
New Residential Investment Corp
F:14N1
|
US |
|
F
|
Fast Retailing Co Ltd
XMUN:FR7
|
JP |
|
PPG Industries Inc
NYSE:PPG
|
US |
|
U
|
UPM-Kymmene Oyj
XMUN:RPL
|
FI |
|
Doximity Inc
NYSE:DOCS
|
US |
Bankruptcy Probability
Merck & Co Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Merck & Co Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
612.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
433B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
142.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
133.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Merck & Co Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Merck & Co Inc has total debt of 46.7B USD. This includes both short-term (0 USD) and long-term (46.7B USD) debt.
You can find a full breakdown on its Balance Sheet.
